Dec 16, 2022

VetStem 2022 Wrap Up

Posted by Bob under VetStem

Well friends, here we are again nearing the end of another year. It’s hard to believe 2022 is almost over. This has been a big year for VetStem, one with a lot of change but also a lot of growth; a new building, new employees, and many new opportunities to educate veterinarians and pet owners about stem cell therapy. As our last blog of the year, we like to give our readers an overview of all that has happened with VetStem in the last 12 months. So, without further ado, here is VetStem’s 2022 year in review.

  • Towards the end of 2021, VetStem announced that we spun out our veterinary division, splitting off from our contract manufacturing division. With this separation, came a new corporate office. While the laboratory remains in the same buildings, our administrative offices have moved for the first time since VetStem opened their doors! Check out some pictures of the new space below.
  • In February, VetStem CEO, Dr. Bob Harman, was invited to present stem cell data at the Global Elephant Endotheliotropic Herpesvirus (EEHV) Symposium. VetStem Cell Therapy has been successfully used to treat this deadly virus in multiple elephants.
  • In March, we announced that we had reached an industry leading milestone: VetStem has processed over 15,000 patient samples and has provided over 35,000 stem cell treatments.
  • In April, we announced our new Chief Development Officer Dr. Anne Hale. Dr. Hale has significant experience in product development and regulatory approval and has led the charge in the development of upcoming VetStem products.
  • In June, Dr. Harman once again had the opportunity to present stem cell data for exotic animals. This time it was at the International Association for Aquatic Animal Medicine (IAAAM) conference. Dr. Harman discussed the use of VetStem Cell Therapy for various aquatic animals including dolphins, sea lions, and sea turtles!
  • Also in October, Dr. Anne Hale delivered a lecture at the annual American Association of Feline Practitioners (AAFP) conference all about the use of VetStem Cell Therapy in cats.
  • Lastly, in November, Dr. Harman was invited to present about the use of real-world evidence in biological treatments at the American Academy of Orthopaedic Surgeons second annual Biologics Symposium. Though Dr. Harman officially represented our human counterpart, Personalized Stem Cells, his talk centered on his use of veterinary stem cell data from VetStem that helped guide the development of our human stem cell clinical trials.

And there you have it. Another year in the books. We thank you for your continued support, without which we couldn’t be here, improving and saving the lives of animals. We wish everyone the happiest of holidays and look forward to seeing what 2023 has in store for VetStem.

Share

Comments are closed.